Experience with efavirenz in end-stage renal disease.
There are few data on the use of highly active antiretroviral therapy in HIV-positive patients with end-stage renal disease. We describe the tolerability, safety and efficacy of an efavirenz-containing regimen in one such patient on continuous ambulatory peritoneal dialysis.
Prime
Katia P
KP
Department of Genitourinary Medicine and HIV, Mortimer Market Centre, Off Capper Street, London WC1E 6AU, UK. katiaprime@hotmail.com
Woolfson
Robin G
RG
Pakianathan
Mark R
MR
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy*; D010078:Oxazines / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz